Antiemetic Strategies in Patients Who Undergo Hematopoietic Stem Cell Transplantation
Abstract Hematopoietic stem cell transplantation (HSCT) is an integral part of the treatment strategy in patients with a hematological disorder. Chemotherapy-induced nausea and vomiting (CINV) is still an issue in patients who undergo HSCT. While several guidelines for the antiemetic therapy against...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAABRON PRESS
2022-07-01
|
| Edice: | Clinical Hematology International |
| Témata: | |
| On-line přístup: | https://doi.org/10.1007/s44228-022-00012-8 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
